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ZebraﬁshAnxiety-related disorders are frequently observed in the population. Because the available pharmacotherapies
for anxiety can cause side effects, new anxiolytic compounds have been screened using behavioral tasks. For ex-
ample, diphenyl diselenide (PhSe)2, a simple organoselenium compound with neuroprotective effects, has dem-
onstrated anxiolytic effects in rodents. However, this compound has not yet been tested in a novelty-based
paradigm in non-mammalian animal models. In this study, we assessed the potential anxiolytic effects of
(PhSe)2 on the behavior of adult zebraﬁsh under novelty-induced stress. The animals were pretreated with
0.1, 0.25, 0.5, and 1 μM (PhSe)2 in the aquarium water for 30 min. The ﬁsh were then exposed to a novel tank,
and their behavior was quantiﬁed during a 6-min trial. (PhSe)2 treatment altered ﬁsh behavior in a
concentration-dependent manner. At 0.01 and 0.25 μM, (PhSe)2 did not elicit effects on ﬁsh behavior. At
0.5 μM,moderate behavioral side effects (e.g., lethargy and short episodic immobility)were noted. At the highest
concentration tested (1 μM), dramatic side effects were observed, such as burst behavior and longer periods of
immobility. The results were conﬁrmed by spatiotemporal analysis of each group. Occupancy plot data showed
dispersed homebase formation in the 0.25 μM (PhSe)2-treated group compared with the control group (treated
with 0.04% DMSO). Furthermore, animals treated with 0.25 μM (PhSe)2 showed a reduction in latency to enter
the top and spent more time in the upper area of the tank. These data suggest that (PhSe)2 may induce an
anxiolytic-like effect in situations of anxiety evoked by novelty.
© 2014 Elsevier Inc. All rights reserved.1. Introduction
Anxiety-related disorders are the most prevalent disorders in the
world population (Anon., 2002). This type of psychiatric condition is
usually a comorbidity associated with a large number of another disor-
ders of the brain (Brooks-Kayal et al., 2013; Caruso et al., 2013; Cheung,
2013), and anxiety involves common neurological circuits (De Masi,
2004). Considering that the available pharmacotherapies for anxiety5 51 33085555; fax: +55 51
.M. Mussulini).may cause several side effects, such as sedation, muscle relaxation,
amnesia, and dependence, new drugs with few undesirable effects
have been screened as candidates for the treatment of anxiety disorders
(Otto et al., 2010; Youssef and Rich, 2008).
Novelty is deﬁned as a new or unfamiliar experience. Due to the lack
of experience in the new situations, the brain identiﬁes novel situations
as stressful moments that induce anxiety-like behaviors. In basic
neuroscience research, the novel tank diving test (or the open tank
paradigm) is an emergent behavioral tool that is used to measure
novelty-associated behavioral stress responses. Fundamentally, this
task consists of assessing the vertical exploratory activity of zebraﬁsh
in a new environment. The task is based on the initial tendency of the
ﬁsh to dive to the bottom and gradually swim to the upper areas of
the new tank (Levin et al., 2007). As demonstrated by Stewart et al.
(2011), this test can be used for investigating pharmacological
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the novel tank test can be used to assess the complete exploratory
and locomotor behavior of zebraﬁsh (Rosemberg et al., 2011). This
perspective allows for the assessment of the potential toxic effects
of classical anxiolytic drugs, such as benzodiazepines (Bencan et al.,
2009), as well as substances that promote anxiolytic-like effects at
low doses and sedation at higher concentrations (Rosemberg et al.,
2012).
In the last several years, many compounds that have demonstrated
anxiolytic effects in rodents have emerged. In this context, interest
in organoselenium compounds has increased because they have
anxiolytic-like (Savegnago et al., 2008), antimicrobial (Kumar et al.,
2010), antineoplastic (Micke et al., 2010) and anti-inﬂammatory
(Duntas, 2009) properties. One interesting selenium-containing mole-
cule is diphenyl diselenide (PhSe)2, which has known pharmacological
effects in rodents (Luchese et al., 2007, 2009; Nogueira and Rocha,
2010; Nogueira et al., 2004; Prigol et al., 2009; Savegnago et al., 2007)
and shows anxiolytic-like effects in the open-ﬁeld and plus-maze tests
(Ghisleni et al., 2008). In chickens, the anxiolytic-like effects of
(PhSe)2 were observed after social separation-stress behavior (Prigol
et al., 2011). Despite the extensive literature describing the anxiolytic
effects of (PhSe)2, it is difﬁcult to validate putative molecular mecha-
nisms that predict toxic effects in mammals. Consequently, the study
of the behavioral effects of diphenyl diselenide in an alternative and
simple animal model is of particular importance. Importantly, aquatic
vertebrates have more selenoproteins than terrestrial organisms, and
(PhSe)2 can partially mimic the activity of selenoproteins (Mariotti
et al., 2012; Nogueira and Rocha, 2010). Furthermore, teleosts have a
narrower range of tolerance to selenium, and the use of the zebraﬁsh
modelmay serve as a primary screening step to investigate the potential
toxicological effects of organo-chalcogen compounds, complementing
the existing rodent approaches. One interesting method for analyzing
the potential pharmacological and toxicological effects of new com-
pounds is the measurement of the behavioral repertoire of the organ-
ism. Animal behavior involves the interaction of an organism with the
surrounding environment. In fact, several behavioral parameters may
be used to predict both the anxiolytic and toxic effects of chemical sub-
stances. Because adult zebraﬁsh display a wide range of behaviors that
have previously been pharmacologically characterized (Kalueff et al.,
2013; Maximino et al., 2011; Rosemberg et al., 2012), the assessment
of the behavioral phenotypes of this speciesmay also reveal the primary
effects of diphenyl diselenide in ﬁsh. Furthermore, because anxiety can
be elicited by various situations in humans, distinct behavioral tasks and
animal models may be used to indicate whether (PhSe)2 maintains its
anxiolytic effects in various anxiogenic situations.
To assess whether (PhSe)2 induces anxiolytic-like behavior in a
stressful condition such as novelty, we used the novel tank paradigm
after acute exposure of zebraﬁsh to (PhSe)2. Moreover, because
selenium compounds have a narrow concentration range between ben-
eﬁcial and toxicological effects, we also performed a thorough screening
of ﬁsh behavior to examine the possible behavioral side effects of
(PhSe)2.
2. Materials and methods
2.1. Animals
Adult zebraﬁsh (Danio rerio; 4 to 6 months old, approximately 50:50
male:female ratio) from a heterogeneous wild-type stock (standard
short-ﬁn phenotype) were obtained from a local commercial supplier
(Delphis, RS, Brazil). The ﬁsh were housed in 50-L aquariums (80–100
ﬁsh per aquarium) for at least 2 weeks prior to the experiments to
allow them to acclimate to the animal facility. All tanks were ﬁlled
with non-chlorinated water previously treated with 132 μL/L AquaSafe
(Tetra, VA, USA) and maintained with mechanical and chemical
ﬁltration at a target temperature of 26 ± 2 °C and a water pH of7.0 to 8.0 (system water). The room illumination was provided by
ceiling-mounted ﬂuorescent lamps on a 14/10 light/dark photoperiod
(lights on at 7:00 a.m.). The animals were fed twice a day with a com-
mercial ﬂake ﬁsh food (Alcon BASIC, Alcon, Brazil) and maintained ac-
cording to the National Institutes of Health Guide for the Care and Use
of Laboratory Animals (2011). All procedures with animal subjects
were approved by the Ethics Committee for the Use of Animals—CEUA
from the Universidade Federal do Rio Grande do Sul. Due to the condi-
tions of protocol approval, maximum efforts were made to minimize
the number of animals used and their suffering.
2.2. Treatments with (PhSe)2 and behavioral analysis
Fish (n= 12 in each group) were individually treated with (PhSe)2
(0.1, 2.5, 0.5, or 1 μM) for 30 min. The (PhSe)2 was prepared in DMSO
and then diluted inwater to the above concentrations (the ﬁnal concen-
tration of DMSO in all solutions of (PhSe)2 was adjusted to 0.04%). The
control group was exposed to system water containing 0.04% DMSO.
After 30min of exposure, the animals were carefully placed individually
in a trapezoidal tank (23.9 cm along the bottom × 28.9 cm at the top,
15.1 cm in height) ﬁlled with home system water. To maintain the
same experimental conditions, all of the experiments were performed
during the same time period each day (from 10:00 a.m. to 4:00 p.m.).
The ﬁsh were randomly handled, removed from their home tanks, and
individually transferred to beakers ﬁlled with the solutions. For each
experiment, a single ﬁsh was placed in each solution, and the solution
was not used in subsequent experiments.
A webcam (Microsoft LifeCam 1.1 with Auto-Focus) was placed in
front of the novel tank to monitor the location and swimming activity
of the zebraﬁsh during the 6-min trial. To ensure a uniform background
for the video analysis and to avoid environmental distraction for
animals subjected to the behavioral test, yellow sheets of paper were
placed 4.3 cm behind the tank and also on both sides of the apparatus.
Two 60-W light bulbs were placed 40 cm behind the novel tank to in-
crease the contrast between the background and the ﬁsh. The webcam
was connected to a laptop for recording the videos. The behavioral
parameters were automatically measured at a rate of 30 frames/s
using appropriate video-tracking software (ANY-maze, Stoelting CO,
USA). During all of the experiments, care was taken to move ﬁsh gently
between home tanks, beakers, and the novel tank to avoid handling
stress. Each experimental group comprised individuals from multiple
batches, and the tank water was replaced with clean system water for
individual trials. All ﬁsh were handled and tested using standardized
procedures (similar manipulation, water quality, and illumination).
2.3. Spatiotemporal analysis of behavior
To design representative ethograms of the (PhSe)2-exposed groups,
the behavioral proﬁles of zebraﬁsh in the novel tank were analyzed
using the track reconstructions of the spatial coordinates over time
(Cachat et al., 2011; Grossman et al., 2010; Rosemberg et al., 2011).
Brieﬂy, the coordinates of the experimental tankwere properly calibrat-
ed using the ANY-maze software, and the tracking data across fractions
of a second for each ﬁsh was exported as raw data into separate spread-
sheets. The exported spatial coordinates (x-center and y-center) were
evaluated based on their similarity to each other by two trained ob-
servers (inter-rater reliability N0.85) on a consensus basis. The middle
tracewas selected as representative of the group to illustrate the spatio-
temporal pattern of exploration. Spatiotemporal reconstructions were
represented as scatter plots, which were constructed using Graphis 3D
graphing software. The x-center (horizontal distribution), y-center
(vertical distribution), and time (z-axis) were plotted. The positions of
the ﬁsh across the trial were represented using a spectrum of colors
(blue–red) to demonstrate the position of the animal during the test
(0–360 s).
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The locomotor activity of zebraﬁsh was measured using the follow-
ing behavioral endpoints: 1) the total distance traveled; 2) the time of
immobility; and 3) the maximum speed. Additionally, the maximum
speed and immobility time were determined in constant time intervals
(5 s) to quantify the pattern of behavioral changes within the trial. The
vertical behavior of a zebraﬁsh in the novel tank represents its tendency
to gradually explore upper areas when exposed to a novel apparatus,
which may reﬂect habituation to the new environment (Rosemberg
et al., 2011; Wong et al., 2010). Moreover, vertical activity (e.g., time
spent at the top of the tank) has been suggested as an indicator of re-
duced anxiety levels (Egan et al., 2009; Levin et al, 2007; Mathur and
Guo, 2011). The exploratory proﬁle of ﬁshwas estimated by quantifying
the horizontal and vertical parameters as described by Rosemberg et al
(2011). We evaluated homebase formation during the novel tank trial,
which is deﬁned as the location in the tank that is preferred by adult
zebraﬁsh over time (Stewart et al., 2010a,b). In summary, the novel
tank was divided into three areas (bottom, middle and top). Each of
the areas was subdivided into ﬁve sections. The occupancy plot, repre-
sented as a heat graph (blue to red), indicates the time that the animals
spent in each section. The homebase is represented as the sectionwhere
the animals spent the most time, interpreted as a “safe” place for
exploration. If the group shows replicable behavior (i.e., no large inter-
individual variation) when all the animals are plotted in a single occu-
pancy plot, variation in color (yellow to red) is observed (Rosemberg
et al., 2011, 2012).
2.5. Statistics
Parametric data were expressed as the means ± standard error of
the mean (S.E.M.) and analyzed by repeated-measures analysis of vari-
ance (ANOVA) using Bonferroni's post hoc test. The results of temporal
analyses of maximum speed and immobility were expressed as the
mean ± S.E.M. and analyzed by two-way ANOVA followed by a multi-
ple comparison test. Differenceswere considered statistically signiﬁcant
at p ≤ 0.05.
3. Results
Animals treated with anxiolytic drugs can exhibit lethargy or epi-
sodes of immobility as side effects. Because there are no studies describ-
ing the effects of (PhSe)2 in zebraﬁsh, we ﬁrst tested this compound at
concentrations ranging from0.1 to 1 μM.Animals exposed to lower con-
centrations of (PhSe)2 (0.1 and 0.25 μM) did not show changes in dis-
tance traveled compared to the control ﬁsh. However, ﬁsh exposed to
higher concentrations (0.5 μMand 1 μM) showed a signiﬁcant reduction
in this parameter (one-way ANOVA, F[4,59] = 33.16, p b 0.0001;Fig. 1.Basic endpoint behaviors used to assess the proper (PhSe)2 concentration range for adult z
speed (C). The datawere analyzedby one-wayANOVA followedbyBonferroni's post hoc test, co
control (black) and (PhSe)2 groups (gray).Bonferroni test, p b 0.05 for both concentrations, respectively)
(Fig. 1A). Animals exposed to 1 μM (PhSe)2 spent more time immobile
(Fig. 1B) and had the highest maximum speed (Fig. 1C) of all groups
(one-way ANOVA, F[4,59] = 4.606, p b 0.001; Bonferroni test, p b 0.05;
one-way ANOVA, F[4,59] = 10.55, p b 0.0001; Bonferroni test, p b 0.05,
respectively). To isolate the effects of 0.5 and 1 μM(PhSe)2, we also per-
formed an analysis of maximum speed over short periods of time (5 s).
Animals exposed to 0.5 μM (PhSe)2 displayed a constant maximum
speed throughout the trial. However, the group exposed to 1 μM
(PhSe)2 showed several peaks ofmaximum speed, indicating the occur-
rence of burst swimming (Fig. 2A) (two-way ANOVA, F[1,22] = 15.90,
p b 0.0001 for both concentrations). Because these peaks of maximum
speed occurred mostly after the ﬁrst minute and anxiolytic drugs can
evoke immobility in zebraﬁsh immediately following the removal of
the drug (Mussulini et al., 2013), we further analyzed the time of immo-
bility during the trial. Fig. 2B shows increased immobility in ﬁsh ex-
posed to 1 μM (PhSe)2, with recurrent episodes of immobility during
the trial (two-way ANOVA, F[4,49] = 4.583, p b 0.001; multiple compar-
ison test, p b 0.01). Thus, the effects of (PhSe)2 on zebraﬁsh behavior
were concentration-dependent. Indeed, low concentrations of (PhSe)2
(0.01 and 0.25 μM) caused no behavioral side effects. An intermediate
concentration (0.5 μM) caused moderate side effects, such as lethargy
(decreased distance and an equal duration of immobility when com-
pared to the control) and brief instances of immobility, and the highest
concentration (1 μM) caused drastic side effects, such as burst swim-
ming and a prolonged period of immobility, with possible toxicity.
We next assessed whether (PhSe)2 could induce anxiolytic-like
effects during a novelty stress condition using representative spatio-
temporal analysis of zebraﬁsh behavior. Importantly, the behaviors of
the control group (exposed to 0.04% DMSO) were similar to those
observed in untreated ﬁsh, which we have previously described
(Rosemberg et al., 2011, 2012). The animals showed a preference for
the bottom area, whereas the middle was primarily used for vertical
transitions, in which animals demonstrated low horizontal exploration
(Fig. 3A). The group exposed to 0.1 μM (PhSe)2 showed an overall
behavioral proﬁle similar to that of the control. This groupused themid-
dle area as a passage to the top and bottom areas, but animals rapidly
approached the top at the beginning of the test (Fig. 3B). The group
treated with 0.25 μM (PhSe)2 showed a different proﬁle, in which the
animals demonstrated initial exploration of the bottomwith fast access
to all vertical areas. In the ﬁnal 3 min of the test, the ﬁsh in this group
changed their exploratory activity, showing a preference for exploring
the top area of the tank (Fig. 3C). The group treated with 0.5 μM
(PhSe)2 showed chaotic behavior. These animals displayed fast transi-
tions to the top and bottom and spent more time in the middle area of
the apparatus (Fig. 3D). Fish exposed to 1 μM (PhSe)2 initially showed
a longer period of immobility at the bottom of the apparatus.
Later, the animals approached the top of the apparatus and showedebraﬁsh. The graph shows the distance traveled (A), time of immobility (B) andmaximum
nsidering p≤ 0.05 as signiﬁcant. Different letters indicate signiﬁcant differences among the
Fig. 2. Analysis of possible toxicological effects on adult zebraﬁsh behavior. Maximum speed over time (A) of ﬁsh exposed to 0.5 μM ( ) and 1 μM ( ) (PhSe)2. Peaks indicate burst
behavior with a signiﬁcant difference between groups (two-way ANOVA, p b 0.0001). Immobility over time (B) compared among all groups. Two-way ANOVA, p b 0.001, followed by a
multiple comparison test, p b 0.01, indicates that only ﬁsh treated with 1 μM (PhSe)2 differed from those in all other groups.
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ity and burst swimming (Fig. 3E).
The occupancy plot analyses showed a progressive decrease in
homebase formation. The control group demonstrated a clear homebase,
with a continuous return to the same location in the bottom area
(Fig. 4A). Animals treated with 0.1 μM (PhSe)2 began to form dispersed
homebases, returning to distinct safe points during the test (Fig. 4B).
The dispersal was more obvious in animals exposed to 0.25 μM (PhSe)2.
This group did not form a speciﬁc homebase, instead exploring the entire
apparatus (Fig. 4C). The occupancyplot analysis conﬁrmed the chaotic be-
havior demonstrated by the animals treated with 0.5 μM (PhSe)2, which
did not have a preference for a particular location in the apparatus
(Fig. 4D). The animals exposed to 1 μM (PhSe)2 had two homebases at
the top of the apparatus and few exploration areas in themiddle (Fig. 4E).
Classical endpoint analysis (Savio et al., 2012) conﬁrmed the behav-
ioral proﬁle described for each group. Animals treated with 1 μM
(PhSe)2 showed a signiﬁcant reduction in the time spent at the bottom
(Fig. 5A) (one-way ANOVA, F[4,59] = 78.30, p b 0.0001; Bonferroni test,
p b 0.05), whereas ﬁsh treated with 0.5 μM (PhSe)2 spent more time in
the middle area of the new tank (Fig. 5B) (one-way ANOVA, F[4,59] =
49.79, p b 0.0001; Bonferroni test, p b 0.05). Regarding the time spent
at the top, no difference between the control and the 0.1 μM (PhSe)2-
treated groups was observed. Animals treated with 0.25 and 1 μM
(PhSe)2 spent more time at the top compared with the control group
(Fig. 5C) (one-way ANOVA, F[4,59] = 187.3, p b 0.0001; Bonferroni test,
p b 0.05). The latency to enter the top showed a clear U-shaped curve,
in which the ﬁsh groups treated with 0.1, 0.25 and 0.5 μM (PhSe)2
showed signiﬁcantly lower latencies to enter the top portion of the
tank when compared with the control group (Fig. 5D) (one-way
ANOVA, F[4,59] = 30.58, p b 0.0001; Bonferroni test, p b 0.05).4. Discussion
In recent years, the zebraﬁsh has emerged as a useful model to study
neuropsychiatric disorders. A recent review by Stewart et al (2012) de-
scribes the potential of zebraﬁsh for studying anxiety-like phenotypes
from a behavioral perspective using the novel tank diving test. In addi-
tion, we have proposed an ethogram for this paradigm, which is also
considered a reliable test for evaluating the overall exploratory proﬁle
of animals during novelty stress (Rosemberg et al., 2011). Furthermore,
the zebraﬁsh model offers new insights for translational neuroscience
research (Stewart et al., 2014) and allows for the exploration of complex
brain disorders (Kalueff et al., 2014).
Anxiety can be elicited by a vast array of experiences. Currently,
there is no speciﬁc behavioral trial that can be used to properly charac-
terize anxiolytic drugs. Nevertheless, approaches from various perspec-
tives using different animal models can maximize the identiﬁcation of
more efﬁcient drugs in preliminary screening experiments (Ramos,
2008; Steenbergen et al., 2011). From this perspective, (PhSe)2 has
demonstrated a potential anxiolytic-like effect on rodents during
behavioral tasks (e.g., a reduction in the number of fecal bolus in the
open-ﬁeld test as well as an increase in the time spent and entries
into the open arm of a plus-maze (Ghisleni et al., 2008) and into the
lit compartment of a light–dark box (Savegnago et al., 2008). Moreover,
chickens treated with (PhSe)2 had low anxiety levels based on a test of
their social separation-stress behavior (Prigol et al., 2011). However, the
present study is the ﬁrst to describe the potential anxiolytic-like effects
of (PhSe)2 when animals are subjected to novelty stress.
The zebraﬁsh exposed to 0.25 μM(PhSe)2 showed a reduction in the
latency to enter the top area of the novel tank. This parameter is an
indicator of low anxiety, which was ﬁrst reported by Levin et al
Fig. 3. Spatiotemporal analysis of adult zebraﬁsh exposed to a range of (PhSe)2 concentrations. Representative spatiotemporal reconstructions of ﬁsh treated with 0.04% DMSO (control)
(A) and 0.1 μM (B), 0.25 μM (C), 0.5 μM (D) and 1 μM (PhSe)2 (E) during the 6 min of the test were obtained by plotting animal traces (X-axis and Y-axis) over time (Z-axis). The test
segments (0–360 s) are represented by a color scale gradient and are shown in the Z-axis (blue to red). Dots in the same spot over time indicate immobility. Dots with a large distance
over short time periods indicate burst behavior.
Fig. 4. Occupancy plot of exploratory activity and homebase formation in the novel tank. Occupancy plots of control (0.04% DMSO) (A) and 0.1 μM (B), 0.25 μM (C), 0.5 μM (D) and 1 μM
(PhSe)2 (E) groups displaying speciﬁc patterns of time spent in each segment of the apparatus during a 6-min trial. Increased time spent in a region indicates homebase formation. The data
were analyzed using video-tracking software (ANY-maze, Stoelting CO, USA).
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Fig. 5.Classical endpoint analysis for the assessment of anxiolytic-like behavior. Thegraph shows time spent at the bottom(A),middle (B), and top (C) aswell as latency to the top (D) area.
The data were analyzed by one-way ANOVA followed by Bonferroni's post hoc test, considering p ≤ 0.05 as signiﬁcant. Distinct letters indicate signiﬁcant differences among the control
(black) and (PhSe)2 groups (gray).
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anxiolytic/anxiogenic drugs (Stewart et al., 2010a, 2011; Wong et al.,
2010). Furthermore, animals treated with 0.25 μM (PhSe)2 explored
the entire apparatus, performing more lateral activity at the top com-
pared with the ﬁsh in the control groups. Typically, control ﬁsh entered
the top area of the tank and rapidly returned to the bottom. Such an al-
teration in the exploration of the top area is also considered an indica-
tion of anxiolytic effects (Rosemberg et al., 2011, 2012). Fish treated
with 0.25 μM (PhSe)2 did not show a preference for any speciﬁc section
of the apparatus. A recent debate about the preferential regions inside
the novel tank led researchers to postulate the possible formation of a
homebase in this apparatus (Stewart et al., 2010a). Recently, homebase
behavior was deﬁned as the tendency to establish a key safe location
that the ﬁsh spendsmore time in and repeatedly returns to after explor-
ing a novel environment (Kalueff et al., 2013). The occupancy plot anal-
ysis showed that animals treatedwith 0.1 μM(PhSe)2 formed dispersed
homebases, and complete abolishment of homebase formation was
observed in animals exposed to 0.25 μM (PhSe)2. The absence of a key
safe location in the bottom area of the tank is associated with an in-
crease in the time spent in the upper area, indicating the anxiolytic-
like effect of (PhSe)2 during a novel experience.
Despite the absence of homebase formation, animals treated with
0.25 μM (PhSe)2 spent more time at the bottom of the tank. Similar re-
sults were observed in the ﬁsh exposed to drugs that evoke anxiolytic-
like effects. Acute exposure to ethanol for 20 min led to increased
exploration of the top area. However, in a 6-min trial, the animals
showed a preference for the bottom, similar to what was observed
with non-exposed ﬁsh (Rosemberg et al., 2012). Moreover, exposure
of animals to 0.25 μM (PhSe)2 for 30 min caused similar anxiolytic-likeeffects in this test compared to treatment with citalopram and desipra-
mine (Sackerman et al., 2010), ﬂuoxetine (Wong et al., 2010),
olanzapine (Seibt et al., 2010), and nicotine (Levin et al., 2007;
Stewart et al., 2010b). However, ﬁsh exposed to 1 μM (PhSe)2 showed
immobility, which was similar to what was observed in zebraﬁsh
exposed to diazepam (Mussulini et al., 2013), or lethargy, which was
also observed in animals immersed in chlordiazepoxide. Reduced diving
and bottom dwelling, which were also observed in ﬁsh treated with
high doses of buspirone (Bencan et al., 2009), were noted as well.
Although these side effects were observed in animal models after treat-
ment with high concentrations of anxiolytic drugs, zebraﬁsh treated
with 1 μM(PhSe)2 also displayed burst swimming, loss of innate prefer-
ence for the bottom, and jumping behavior.
Selenium (Se) is an essentialmicronutrient for all vertebrate species,
and it has a narrowmargin between essentiality and toxicity in ﬁsh and
vertebrates (Maher et al., 2010). Dietary selenomethionine, an organic
selenium compound, showed a similar narrowmargin for toxicity com-
pared to inorganic forms (Thomas and Janz, 2011). Indeed, selenite in
water was able to produce changes in the swimming performance of
zebraﬁsh (Massé et al., 2012). Therefore, the chaotic behavior shown
by the animals exposed to 0.5 μM(PhSe)2, the U-shaped curve observed
in the latency to enter the top, and the episodic immobility and burst
swimming observed in the 1 μM-treated group may be due to the
potential toxicity of (PhSe)2.
Because we aimed to verify that (PhSe)2 demonstrates anxiolytic-
like effects in zebraﬁsh subjected to novelty stress, only the treated
groups that did not show signiﬁcant changes in swimming performance
(distance traveled, episodes of immobility) were considered to provide
support for this aim. Although animals exposed to 1 μM (PhSe)2 spent
193M. Ibrahim et al. / Progress in Neuro-Psychopharmacology & Biological Psychiatry 54 (2014) 187–194more time at the top, which is a remarkable characteristic observed
in ﬁsh treated with anxiolytic compounds, this concentration clearly
induced other side effects. Therefore, we assume that only (PhSe)2
concentrations of 0.1 μM (lower latency to the top area and initial dis-
persal of homebase formation) and 0.25 μM (lower latency, more time
spent at the top and abolishment of homebase formation) evoked
anxiolytic-like behavior in zebraﬁsh in a gradual manner. However, a
full understanding of homebase abolishment and its use in anxiety
drug screening requires further study. Therefore, the zebraﬁsh appears
to be an excellent animalmodel for testing the effects of organoselenium
compounds due to the narrow margin between desirable pharmacolog-
ical effects and toxic effects in ﬁsh. This characteristic can minimize the
number and groups of animals needed in trials, which is an important
consideration in the ethical debate concerning animal experimentation
(Mandal and Parija, 2013).5. Conclusion
This study demonstrates the potential anxiolytic effect of (PhSe)2 dur-
ing novelty stress using the novel tank diving test. Furthermore, we are
the ﬁrst to show the effects of different concentrations of (PhSe)2 on
zebraﬁsh behavior. Because distinct models of pathologies (Alfaro et al.,
2011; Braga et al., 2013; Lu et al., 2013; Song and Pimplikar, 2012;
Stewart et al., 2013) and drug abuse (Kyzar et al., 2012; Maximino et al.,
2011) have been studied using this species, our narrow exposure concen-
tration curve can be used to evaluate the role of (PhSe)2 as a protective
compound in such situations. Finally, we hope that our data can provide
researchers with an additional insights to further understand homebase
behavior and its use in future anxiolytic drug discovery.Acknowledgments
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